Carbon monoxide inhibits endothelin-1 release by human pulmonary artery smooth muscle cells

Eur J Pharmacol. 2004 Feb 23;486(3):349-52. doi: 10.1016/j.ejphar.2003.12.026.

Abstract

Endothelin-1 is a potent vasoconstrictor with mitogenic properties. This 21-amino-acid protein, released in the vasculature by endothelial and smooth muscle cells, has been implicated in pulmonary hypertension. More recently, evidence has accumulated for a role of the heme oxygenase system in pulmonary hypertension. Heme oxygenase catalyses the breakdown of heme to produce carbon monoxide, biliverdin and free iron. Here we show that a carbon monoxide-releasing molecule, but not biliverdin, inhibits endothelin-1 release from serum-stimulated human pulmonary artery smooth muscle cells. Under certain conditions, carbon monoxide appears to act as an endogenous break on endothelin-1 release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biliverdine / metabolism
  • Biliverdine / pharmacology
  • Carbon Monoxide / metabolism*
  • Carbon Monoxide / pharmacology
  • Cells, Cultured
  • Endothelin-1 / metabolism*
  • Heme Oxygenase (Decyclizing) / metabolism
  • Humans
  • Interferon-gamma / pharmacology
  • Myocytes, Smooth Muscle / cytology
  • Myocytes, Smooth Muscle / metabolism*
  • Pulmonary Artery / cytology
  • Pulmonary Artery / metabolism*
  • Serum
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Endothelin-1
  • Tumor Necrosis Factor-alpha
  • Carbon Monoxide
  • Interferon-gamma
  • Heme Oxygenase (Decyclizing)
  • Biliverdine